149 related articles for article (PubMed ID: 31638204)
1. Chloroquine promotes gefitinib‑induced apoptosis by inhibiting protective autophagy in cutaneous squamous cell carcinoma.
Ou C; Liu H; Ding Z; Zhou L
Mol Med Rep; 2019 Dec; 20(6):4855-4866. PubMed ID: 31638204
[TBL] [Abstract][Full Text] [Related]
2. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
[TBL] [Abstract][Full Text] [Related]
3. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
[TBL] [Abstract][Full Text] [Related]
4. Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.
Wright TJ; McKee C; Birch-Machin MA; Ellis R; Armstrong JL; Lovat PE
Clin Exp Dermatol; 2013 Jun; 38(4):421-3. PubMed ID: 23530461
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib-mediated apoptosis is enhanced via inhibition of autophagy by chloroquine diphosphate in cutaneous squamous cell carcinoma cells.
Wang J; Wang C; Hu X; Yu C; Zhou L; Ding Z; Zhou M
Oncol Lett; 2019 Jul; 18(1):368-374. PubMed ID: 31289508
[TBL] [Abstract][Full Text] [Related]
6. mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.
Zheng Y; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Oct; 15(1):66. PubMed ID: 28978341
[TBL] [Abstract][Full Text] [Related]
7. EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2.
Lv XX; Zheng XY; Yu JJ; Ma HR; Hua C; Gao RT
Cancer Med; 2020 Feb; 9(3):1131-1140. PubMed ID: 31823521
[TBL] [Abstract][Full Text] [Related]
8. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Lu H; Li X; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.
Tang MC; Wu MY; Hwang MH; Chang YT; Huang HJ; Lin AM; Yang JC
PLoS One; 2015; 10(3):e0119135. PubMed ID: 25807554
[TBL] [Abstract][Full Text] [Related]
10. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
Kang M; Lee KH; Lee HS; Jeong CW; Kwak C; Kim HH; Ku JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165387
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
[TBL] [Abstract][Full Text] [Related]
12. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
13. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
Liu H; Li L; Li XQ; Liu XJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):41-9. PubMed ID: 19342999
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC.
Xia X; Liu Y; Liao Y; Guo Z; Huang C; Zhang F; Jiang L; Wang X; Liu J; Huang H
Eur J Pharmacol; 2019 Aug; 856():172409. PubMed ID: 31132355
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
To KKW; Wu WKK; Loong HHF
Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
[TBL] [Abstract][Full Text] [Related]
16. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid sensitizes human glioma cells to gefitinib-induced autophagy.
Chang CY; Li JR; Wu CC; Ou YC; Chen WY; Kuan YH; Wang WY; Chen CJ
IUBMB Life; 2015 Nov; 67(11):869-79. PubMed ID: 26488897
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.
Yoshimoto M; Hirata M; Kanai Y; Naka S; Nishii R; Kagawa S; Kawai K; Ohmomo Y
Biol Pharm Bull; 2014; 37(3):355-60. PubMed ID: 24583857
[TBL] [Abstract][Full Text] [Related]
19. Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B.
Bi X; Jiang Z; Luan Z; Qiu D
Bioengineered; 2021 Dec; 12(1):4569-4580. PubMed ID: 34320900
[TBL] [Abstract][Full Text] [Related]
20. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
